Filing Details
- Accession Number:
- 0001127602-15-012201
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-20 16:30:05
- Reporting Period:
- 2015-03-19
- Filing Date:
- 2015-03-20
- Accepted Time:
- 2015-03-20 16:30:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1452635 | S Yarlagadda Babu | 4505 Emperor Blvd. Suite 200 Durham NC 27703 | Senior Vp - Drug Discovery | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-19 | 12,105 | $10.16 | 148,697 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.15 to $10.19. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Billionaire Hedge Funds
